1. Home
  2. KWR vs VCEL Comparison

KWR vs VCEL Comparison

Compare KWR & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quaker Houghton

KWR

Quaker Houghton

HOLD

Current Price

$134.61

Market Cap

2.2B

Sector

Industrials

ML Signal

HOLD

Logo Vericel Corporation

VCEL

Vericel Corporation

BUY

Current Price

$36.68

Market Cap

2.0B

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
KWR
VCEL
Founded
1918
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.0B
IPO Year
1985
1997

Fundamental Metrics

Financial Performance
Metric
KWR
VCEL
Price
$134.61
$36.68
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
6
Target Price
$149.25
$60.40
AVG Volume (30 Days)
135.6K
626.9K
Earning Date
10-30-2025
11-06-2025
Dividend Yield
1.49%
N/A
EPS Growth
N/A
236.54
EPS
N/A
0.25
Revenue
$1,864,242,000.00
$258,716,999.00
Revenue This Year
$3.44
$17.86
Revenue Next Year
$4.15
$18.55
P/E Ratio
N/A
$149.06
Revenue Growth
0.08
14.05
52 Week Low
$95.91
$29.24
52 Week High
$161.47
$63.00

Technical Indicators

Market Signals
Indicator
KWR
VCEL
Relative Strength Index (RSI) 51.30 44.89
Support Level $133.49 $37.28
Resistance Level $138.90 $42.68
Average True Range (ATR) 4.86 1.80
MACD 0.24 -0.50
Stochastic Oscillator 54.42 4.42

Price Performance

Historical Comparison
KWR
VCEL

About KWR Quaker Houghton

Quaker Houghton manufactures and sells a variety of industrial process fluids. The product portfolio of the company includes metal removal fluids, cleaning fluids, corrosion inhibitors, metal drawing and forming fluids, die-cast mold releases, heat treatment and quenchants, metal forging fluids, hydraulic fluids, specialty greases, offshore sub-sea energy control fluids, rolling lubricants, rod and wire drawing fluids and surface treatment chemicals. The geographic segments of the company include America, EMEA, Asia/Pacific, and Global Specialty Businesses. The majority of the revenue is earned from America.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: